產(chǎn)品信息

產(chǎn)品簡介

Sitagliptin phosphate monohydrate is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extractsSitagliptin is an oral antihyperglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It was developed and is marketed by Merck & Co. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of this medicine is its lower side-effects (e.g., less hypoglycemia, less weight gain) in the control of blood glucose values. Exenatide (Byetta) also works by its effect on the incretin system.system。

產(chǎn)品特性

1） CAS NO：654671-77-9

2） 同義名：磷酸西他列汀(一水)，MK-0431,Januvia?，MK0431

3） 分子式：C16H18F6N5O5P     

4） 分子量：523.32

5） 外觀：固體粉末

6） 純度：>99%

7） 溶解性：溶于DMSO

保存與運(yùn)輸方法

保存：2-8℃避光干燥保存，至少2年有效。 

運(yùn)輸：室溫運(yùn)輸。

注意事項(xiàng)

1） 本品儲(chǔ)存液置于≤-20℃避光保存，盡量避免反復(fù)凍融。通常情況下，-20℃至少一個(gè)月穩(wěn)定，-80℃至少6個(gè)月穩(wěn)定。

2） 本品僅用作科研用途，絕不可用于臨床診斷或治療藥物，絕不可用做食品或藥品。

3)為了您的安全和健康，請穿實(shí)驗(yàn)服并戴一次性手套操作。

Sitagliptin phosphate monohydrate的具體使用濃度請參考相關(guān)文獻(xiàn)，并根據(jù)自身實(shí)驗(yàn)條件（如實(shí)驗(yàn)?zāi)康模?xì)胞種類，培養(yǎng)特性等）進(jìn)行摸索和優(yōu)化。

相關(guān)產(chǎn)品